1. Wu R, Li R. Propylthiouracil-induced autoimmune syndromes: 11 case report. Rheumatol Int. 2012;32:679–81.
2. Poomthavorn P, Mahachoklertwattana P, Tapaneya-Olarn W, et al. Antineutrophilic cytoplasmic antibody-positive systemic vasculitis associated with propylthiouracil therapy: report of 2 children with Graves’ disease. J Med Assoc Thai. 2002;85(Suppl 4):S1295–301.
3. Kudoh Y, Kuroda S, Shimamoto K, et al. Propylthiouracil-induced rapidly progressive glomerulonephritis associated with antineutrophil cytoplasmic autoantibodies. Clin Nephrol. 1997;48:41–3.
4. Xu X, Zhao M, Zhang Y, et al. Clinicopathological characteristics of propylthiouracil-induced antineutrophil cytoplasmic antibodies-positive vasculitis and their target antigens: a report of 4 cases and literature review. Zhonghua Nei Ke Za Zhi. 2002;41:404–7.
5. Noh JY, Yasuda S, Sato S, et al. Clinical characteristics of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis caused by antithyroid drugs. J Clin Endocrinol Metab. 2009;94:2806–11.